Dihydromunduletone (DHM) is a selective and potent antagonist of adhesion G protein-coupled receptors (aGPCRs), specifically GPR56 and GPR114/ADGRG5, with an IC50 of 20.9 μM for GPR56; it does not inhibit GPR110 or class A GPCRs. It effectively suppresses GPR56- and GPR114-mediated G protein activation in vitro, significantly reducing the rate of GPR56-stimulated G13 activation by over 75% and potently inhibiting GPR114-stimulated Gs activity. DHM antagonizes both synthetic peptide agonist- and tethered peptide agonist-mediated aGPCR activation in isolated membranes and HEK293T cell-based assays, without affecting basal receptor signaling.